Device Industry Continues Push To Influence Health Care Reform Dialogue
This article was originally published in The Gray Sheet
With comprehensive U.S. health care reform being viewed as a realistic near-term objective among key figures on Capitol Hill, a seat at the decision-making table is perhaps the best any one interest group could hope for - and signs suggest device firms have not been left idly standing
You may also be interested in...
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.
AdvaMed CEO Steve Ubl is leaving the device trade association to take the helm of the Pharmaceutical Research and Manufacturers of America. Ubl has led AdvaMed for 10 years, raising the profile of the device industry among policymakers, fighting perception battles and, of course, opposing the device tax.